About MiMedx Group, Inc. 
MiMedx Group, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 53 Schemes (19.52%)
Foreign Institutions
Held by 89 Foreign Institutions (7.06%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
59 Million
(Quarterly Results - Mar 2026)
Net Profit:
-11 Million
Pharmaceuticals & Biotechnology
USD 569 Million (Micro Cap)
12.00
NA
0.00%
-0.57
18.94%
2.22






